Frank Rimerman Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$51.7M |
| 2 |
Apple
AAPL
|
+$51.5M |
| 3 |
NVIDIA
NVDA
|
+$41M |
| 4 |
Amazon
AMZN
|
+$29.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$26.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procept Biorobotics
PRCT
|
+$4.16M |
| 2 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$1.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01M |
| 4 |
HAPN
Happen Inc
HAPN
|
+$171K |
| 5 |
Sunrun
RUN
|
+$78.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.72% |
| 2 | Communication Services | 11.28% |
| 3 | Healthcare | 7.21% |
| 4 | Financials | 6.88% |
| 5 | Consumer Discretionary | 5.69% |
Similar funds
Frank Rimerman Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Frank Rimerman Advisors held 546 positions worth $1.41B, up 172% from $520M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Frank Rimerman Advisors deployed $825M of net new capital in Q2 2024, opening 210 new positions and adding to 263 existing holdings. Its largest new stake was Duolingo: 99,828 shares worth $20.8M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 10% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Procept Biorobotics, an estimated $4.16M trimmed.
- Frank Rimerman Advisors's largest Q2 2024 buy was Duolingo: 99,828 shares worth $20.8M.
- Frank Rimerman Advisors added most to Microsoft in Q2 2024, an estimated $51.7M increase.
- Frank Rimerman Advisors's biggest Q2 2024 reduction was Procept Biorobotics, cutting an estimated $4.16M.
- Frank Rimerman Advisors fully exited Happen Inc in Q2 2024, selling an estimated $171K.
- Frank Rimerman Advisors's ten largest holdings make up 41% of its $1.41B portfolio in Q2 2024.
- Frank Rimerman Advisors opened 210 new positions and closed 8 in Q2 2024.
- Frank Rimerman Advisors's portfolio value rose 172% quarter-over-quarter to $1.41B.
Based on Frank Rimerman Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.